Medical-grade vs craft cannabis: a sourcing audit

Why the distinction is more than marketing

"Medical-grade" is a phrase that gets attached to cannabis flower in marketing copy regardless of whether it describes anything real. For a licensed Australian or European importer evaluating a supplier, the word doesn't matter; the underlying systems do. A flower destined for a patient prescription needs to satisfy verifiable criteria across cultivation, manufacture, batch-level testing, and documentation. A flower destined for a recreational dispensary in a less-regulated market doesn't.

This piece is for procurement professionals at licensed importers who need a concrete, defensible answer to "what makes this medical-grade?" — one that survives an audit, a regulator query, or a clinical adverse-event review.

What medical-grade actually means, in four verifiable axes

Strip away the marketing and "medical-grade cannabis" reduces to four properties, each of which a licensed importer can verify with paperwork before signing supply.

1. Cultivation discipline

Recreational and craft cannabis can be grown well, but it doesn't have to be grown to documented standards. Medical-grade cannabis does. Thailand's domestic standard is TH-GACP (Good Agricultural and Collection Practices for medicinal plants), administered by the Department of Thai Traditional and Alternative Medicine. Equivalent standards in other jurisdictions include EU GACP, Israel IMC-GAP, and Health Canada's standardised cultivation framework.

What TH-GACP (or any GACP regime) actually requires:

• Site licensing and personnel qualification
• Documented seed-to-harvest protocols
• Pest management with declared chemistry inputs
• Water source testing
• Drying, curing, and storage SOPs
• Record retention sufficient for full batch traceability

A cultivator who can produce a current TH-GACP certificate, the underlying audit report, and recent inputs logs is operating to medical standards. A cultivator who can't isn't — regardless of how the flower looks or smells. The distinction here is systemic: medical-grade is about reproducibility under audit, not about peak quality on the best day.

2. Post-harvest manufacture

Cultivation produces flower; post-harvest processing produces the actual SKU that ships. The medical-grade tier requires this stage to operate under GMP-equivalent conditions:

• Trim, cure, and packaging in environmentally controlled rooms (temperature, humidity, particulate)
• Personnel gowning and contamination protocols
• Equipment cleaning logs between batches
• Batch separation — a "batch" is the smallest unit that gets a single CoA, traceable through packaging
• Tamper-evident seals on retail-unit packaging

Most craft cannabis is processed in well-run but documentation-light facilities. Medical-grade processing produces a paper trail that lets you reconstruct exactly what happened to a specific batch from harvest day to shipment day. That paper trail is what holds up in a regulator query when a patient reports an adverse event.

3. Batch consistency

A patient prescribed a specific cannabinoid ratio for a specific indication needs that ratio to remain stable across re-fills. This is the hardest property to deliver and the most important for clinical use.

Concretely, batch consistency in medical-grade cannabis means:

• Cultivar lock — the same genetic line produces the same flower for the duration of the supply contract. Strain swaps, even of similar names, are notified and re-tested.
• Cannabinoid-ratio tolerance band — typically ±10–15% of the labelled value. Outside that band, the batch isn't shipped to medical channels.
• Terpene profile stability — major terpenes within a defined range. Minor terpenes may vary more, but the dominant therapeutic terpenes (myrcene, β-caryophyllene, limonene) hold within tolerance.
• Documented growing conditions — light cycles, nutrient schedules, environmental setpoints replicated batch to batch.

Craft cannabis prides itself on terroir variability — that this season's flower carries the marks of this season's conditions. Medical-grade cannabis prides itself on the opposite: this season's flower is therapeutically equivalent to last season's, because the patient depends on it being so.

4. Documentation rigour

The fourth axis is the one that ties the previous three together: every claim above is provable on demand. For each batch shipped, a medical-grade supplier produces:

• ISO/IEC 17025-accredited Certificate of Analysis covering cannabinoids, terpenes, microbial limits, residual solvents, heavy metals, pesticide residues, mycotoxins, moisture and water activity. Methods named, LoQs reported.
• Cultivation record — site, harvest date, drying duration, cure duration, propagation source.
• Post-harvest record — processing date, room conditions, packaging lot, packaging operator.
• Cold-chain documentation — temperature and humidity logs from packing through container handover.
• Retained samples — physical samples held at the manufacturer for the documented shelf life, available for re-test on importer request.
• Export licence and CITES documentation where applicable.

When a TGA inspector or a procurement auditor asks "show me the documentation for batch 2026-04-A18," a medical-grade supplier delivers the above within hours. A craft supplier delivers a CoA, possibly. The difference isn't quality of the flower; it's whether the system around the flower stands up to scrutiny.

What licensed importers actually verify before signing

In practice, before signing supply with a Thai cultivator, a serious Australian or European importer asks for:

1. Current TH-GACP certificate (or equivalent regional standard)
2. A sample CoA for a recently shipped batch, full panel
3. Cultivation site audit report (third-party where possible)
4. Post-harvest facility documentation including SOPs and recent batch records
5. Cold-chain protocol with example temperature log
6. References — names of existing licensed importers in regulated markets

Items 1–5 are paperwork. Item 6 is reputation. Together they tell you whether the supplier is operating at medical-grade standards or marketing to that effect.

If a supplier can't provide items 1–5 within a week of request, they aren't medical-grade. If they can, they likely are — and items 4 and 5 separate the truly export-ready operations from the merely certified ones.

Where craft and medical overlap (and where they don't)

Some of the world's best-tasting and most distinctive cannabis is craft. The distinction in this piece isn't aesthetic — craft cultivars often have terpene profiles and cannabinoid expressions that medical operations can't replicate at scale.

The distinction is about what the supply chain can guarantee:

A craft flower may be objectively higher quality than a given medical-grade batch on any single sensory metric. But it can't enter a regulated medical supply chain because the supply chain can't trace, document, and reproduce it. Those properties — not the sensory profile — are what the regulated market requires.

What this means for patients

A patient prescribed CBD-dominant flower for refractory paediatric epilepsy is not a connoisseur. They don't need terroir; they need reproducibility — the same cannabinoid profile, the same dosing predictability, the same therapeutic window, every refill. Medical-grade cultivation, manufacture, consistency, and documentation exist to deliver exactly that.

When a patient's seizure control improves on a specific cultivar at a specific dose, they need that cultivar at that dose to remain available — not "something similar" or "this season's interpretation of." Medical-grade is, fundamentally, the system that holds reproducibility against the natural variability of an agricultural product. That's what the licensed importer is buying.

How CannaBless operates

We supply Australian licensed importers because that's the standard our cultivation, post-harvest, and documentation systems were built to meet. Concretely, every CannaBless supply relationship comes with:

• Current TH-GACP certification with cultivation site identifier
• ISO/IEC 17025-accredited CoA per batch, full panel
• Cultivar genetic record with cannabinoid-ratio tolerance committed in writing
• GMP-equivalent post-harvest facility with documented SOPs
• Cold-chain protocol with continuous logging
• Retained samples per batch for the labelled shelf life
• A named compliance contact with same-day response in business hours

If you're a licensed importer evaluating Thai supply, the documentation pack is what you should ask for first. If a supplier can't provide it, the conversation stops there. Patients depend on the difference being real, not asserted.